Jubilant Pharmova receives credit rating for proposed NCD issuance
(14 Oct 2026)

Back
Jubilant Pharmova has received the credit rating ICRA AA+; Stable for proposed non-convertible debentures worth Rs 1,400 crore.

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew